Metformin

This classification denotes an anti-diabetic agent with the molecular formula C4H11N5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 9100L32L2N, chemically known as 1,1-dimethylbiguanide but more generally known as metformin, which bears US NIH Compound Identifier 4091. European Medicines Agency schedules Metformin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08831MIG. The term METFORMIN is an International Non-Proprietary Name WHO schedules metformin in its Anatomical Therapeutic Chemical (ATC) Classification. METFORMIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule metformin under HS 29252900 and SITC 51482. As of Q4 2014, METFORMIN remains US FDA's Preferred Term for this commodity. Metformin bears US NLM identifiers UMLS ID C0025598 and NCI Concept Code C61612. SMILES: N(C)(C)C(=N)/N=C(/N)N.